Monoclonal Antibody Products

Monoclonal antibodies (mAbs) are essential instruments in modern molecular biology, providing the unparalleled target specificity required for rigorous diagnostics, structural biology, and therapeutic development. By binding exclusively to a single highly specific epitope, mAbs eliminate the cross-reactivity and background noise frequently associated with polyclonal sera.

At Creative Biolabs, we leverage over two decades of biomolecular expertise to engineer and manufacture mAbs that meet the most stringent analytical demands. While our foundational capabilities encompass established methodologies like hybridoma technology for in vivo affinity maturation and phage display for in vitro screening of toxic or non-immunogenic targets, our primary focus and advanced proficiency lie in the generation of recombinant monoclonal antibodies.

Through sophisticated cloning and mammalian expression systems, we transition antibody production from cell-line dependency to sequence-defined certainty. By isolating the specific heavy and light chain variable sequences (V_H and V_L) and integrating them into high-yield expression vectors, we produce recombinant mAbs in HEK293 and CHO cell lines. This methodology guarantees the precise post-translational modifications necessary for optimal binding kinetics and functional efficacy, providing researchers with reagents of absolute biological consistency.

Fig.1 (Creative Biolabs Authorized)

The Creative Biolabs Monoclonal Antibody Advantages

Absolute Specificity

Stringent screening ensures our mAbs differentiate between highly homologous protein isoforms and specific post-translational modifications.

Lot-to-Lot Consistency

Recombinant expression guarantees that the antibody you order today performs exactly identically to the one you order years from now.

Rigorous Validation

Core catalog products undergo multi-platform verification, including target Knockout (KO) or Knockdown (KD) validation, confirming ultimate specificity.

Scalable Mammalian Expression

From transient transfections yielding milligrams for early-stage screening to stable pool generation for gram-level preclinical production, our mammalian cell platforms ensure high volumetric yields without compromising protein folding or solubility.

Related Services

Antibody Conjugation Service Custom Immunoassay Service Antibody Array Analysis Service

Frequently Asked Questions (FAQs)

The definitive advantage is sequence control. Recombinant antibodies eliminate the risk of hybridoma cell line instability or loss. Because the antibody is defined by a digital DNA sequence, it can be expressed indefinitely with absolute lot-to-lot reproducibility, making it the superior choice for long-term diagnostic or therapeutic projects.

Yes. We offer specialized hybridoma sequencing services. We can extract the mRNA from your existing cell line, amplify the variable heavy and light chain regions, sequence them, and clone them into our expression vectors. This secures your intellectual property and upgrades your reagent to a stable recombinant format.

Mouse mAbs are highly reliable and cost-effective for standard targets. Rabbit mAbs possess a superior immune system capable of generating higher-affinity antibodies, making them ideal for recognizing subtle structural variations or targets that are poorly immunogenic in mice.

For projects where the variable region sequences are already known and provided by the client, gene synthesis, vector construction, transient expression, and Protein A/G purification can be completed in as little as 4 to 6 weeks. Full custom discovery projects (antigen design to purified mAb) vary based on the selected discovery platform.